15-90798369-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000057.4(BLM):c.3358+32T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,603,142 control chromosomes in the GnomAD database, including 23,968 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2153 hom., cov: 32)
Exomes 𝑓: 0.17 ( 21815 hom. )
Consequence
BLM
NM_000057.4 intron
NM_000057.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.297
Publications
11 publications found
Genes affected
BLM (HGNC:1058): (BLM RecQ like helicase) The Bloom syndrome is an autosomal recessive disorder characterized by growth deficiency, microcephaly and immunodeficiency among others. It is caused by homozygous or compound heterozygous mutation in the gene encoding DNA helicase RecQ protein on chromosome 15q26. This Bloom-associated helicase unwinds a variety of DNA substrates including Holliday junction, and is involved in several pathways contributing to the maintenance of genome stability. Identification of pathogenic Bloom variants is required for heterozygote testing in at-risk families. [provided by RefSeq, May 2020]
BLM Gene-Disease associations (from GenCC):
- Bloom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Orphanet, Genomics England PanelApp, ClinGen
- osteosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 15-90798369-T-G is Benign according to our data. Variant chr15-90798369-T-G is described in ClinVar as Benign. ClinVar VariationId is 254780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BLM | NM_000057.4 | c.3358+32T>G | intron_variant | Intron 17 of 21 | ENST00000355112.8 | NP_000048.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BLM | ENST00000355112.8 | c.3358+32T>G | intron_variant | Intron 17 of 21 | 1 | NM_000057.4 | ENSP00000347232.3 |
Frequencies
GnomAD3 genomes AF: 0.165 AC: 25028AN: 152114Hom.: 2152 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25028
AN:
152114
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.155 AC: 38443AN: 248226 AF XY: 0.153 show subpopulations
GnomAD2 exomes
AF:
AC:
38443
AN:
248226
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.170 AC: 247220AN: 1450910Hom.: 21815 Cov.: 29 AF XY: 0.168 AC XY: 121456AN XY: 721856 show subpopulations
GnomAD4 exome
AF:
AC:
247220
AN:
1450910
Hom.:
Cov.:
29
AF XY:
AC XY:
121456
AN XY:
721856
show subpopulations
African (AFR)
AF:
AC:
5305
AN:
33276
American (AMR)
AF:
AC:
4199
AN:
44266
Ashkenazi Jewish (ASJ)
AF:
AC:
4290
AN:
25998
East Asian (EAS)
AF:
AC:
6953
AN:
39418
South Asian (SAS)
AF:
AC:
7544
AN:
85238
European-Finnish (FIN)
AF:
AC:
7666
AN:
52442
Middle Eastern (MID)
AF:
AC:
811
AN:
5716
European-Non Finnish (NFE)
AF:
AC:
200508
AN:
1104514
Other (OTH)
AF:
AC:
9944
AN:
60042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
8978
17956
26933
35911
44889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6824
13648
20472
27296
34120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.165 AC: 25051AN: 152232Hom.: 2153 Cov.: 32 AF XY: 0.160 AC XY: 11893AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
25051
AN:
152232
Hom.:
Cov.:
32
AF XY:
AC XY:
11893
AN XY:
74426
show subpopulations
African (AFR)
AF:
AC:
6610
AN:
41526
American (AMR)
AF:
AC:
1746
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
595
AN:
3468
East Asian (EAS)
AF:
AC:
925
AN:
5186
South Asian (SAS)
AF:
AC:
449
AN:
4828
European-Finnish (FIN)
AF:
AC:
1541
AN:
10608
Middle Eastern (MID)
AF:
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12726
AN:
68000
Other (OTH)
AF:
AC:
325
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1079
2158
3236
4315
5394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
479
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Bloom syndrome Benign:3
Apr 06, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.